Clinical Trials Sponsored by Mandi Newton

Total 452 results

Mandi Newton
IWK Health Centre

Completed

Evaluating an Internet-based Program for Anxious Youth: a Pilot RCT

Anxiety

Canada
Newton-Wellesley Hospital

Unknown

Use of the LRU Pillow in the Acute Setting Following Total Knee Arthroplasty (LRU)

Osteoarthritis

United States
Newton-Wellesley Hospital

Completed

Comparison of the Effectiveness of Mobilization and Manipulation of the Thoracic Spine in Patients With Mechanical Neck Pain

Neck Pain

United States
Magdi H. Yacoub

Recruiting

Effects of Treprostinil on Right Ventricular Structure and Function in Patients With Pulmonary Arterial Hypertension

Pulmonary Hypertension

Egypt
Maadi Military Hospital

Unknown

Study to Justify Steroid Use in Preterm Neonates to Prevent Bronchopulmonary Dysplasia

Bronchopulmonary Dysplasia

Egypt
Mando Group AB

Completed

Reduction of the Speed of Eating as an Intervention in Obesity

Binge-Eating Disorder

Sweden
Magdi Yacoub Heart Foundation

Recruiting

AHC Ballana Heart Study (AHC-BHS)

Genetic Predisposition to Disease

Egypt
Daniel Landi

Terminated

EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma (ExCeL)

Glioblastoma | Gliosarcoma

United States
Newton-Wellesley Hospital
Pfizer

Withdrawn

Fibromyalgia of Less Than One Year Duration. Study of Pregabalin

Fibromyalgia

United States
Magdi Yacoub Heart Foundation

Unknown

Rheolytic Thrombectomy in Patients With Acute STEMI and Large Thrombus Burden (Rheo-STEMI)

ST Elevation Myocardial Infarction | STEMI

Egypt
Faculty Sao Leopoldo Mandic Campinas

Completed

Efficacy of Hall Technique in Atypical Lesions on Primary Teeth (SLM2078)

Dental Caries

Brazil
Faculty Sao Leopoldo Mandic Campinas

Completed

Selective Dentine Removal in Primary Teeth

Caries, Dental

Brazil
Faculty Sao Leopoldo Mandic Campinas

Unknown

Randomized Trial to Evaluate the Efficacy of Two Different Toothbrushes on Plaque Control

Gingivitis | Plaque
Lund University
Newton-Wellesley Hospital

Completed

Management of Chronic Pain

Chronic Pain

United States
Magdi Yacoub Heart Foundation

Recruiting

Egyptian Hypertrophic Cardiomyopathy Program

Hypertrophic Cardiomyopathy

Egypt
Magdi Yacoub Heart Foundation

Recruiting

Aswan Heart Centre - Egyptian Healthy Volunteers (AHC-EHVol)

Genetic Predisposition to Disease

Egypt
Newron Pharmaceuticals SPA

Completed

Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia

Schizophrenia

India, United States
Newron Sweden AB

Terminated

A Study With an Increased Dose Step in Patients That Have Previously Received Placebo or sNN0031.

Parkinson's Disease

Sweden
Newron Pharmaceuticals SPA

Completed

A Trial to Explore the Potential Benefit of Safinamide on Cognitive Impairment Associated With Parkinson's Disease

Parkinson's Disease With Cognitive Impairments

Spain, United States
Newron Pharmaceuticals SPA

Completed

Safinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist (12 Month Extension)

Parkinson's Disease
Newron Pharmaceuticals SPA

Unknown

An Open Label, Single-Dose Study of 14C-NW-3509 in Healthy Male Subjects

Healthy

United Kingdom
Newron Pharmaceuticals SPA

Completed

A Phase I- Sequential Cohort Dosing to Determine Maximum Tolerated Dose in Healthy Male Volunteers.

Schizophrenia

United States
Newron Sweden AB

Terminated

A follow-on Study to Assess Long-term Safety and Tolerability of i.c.v Administration of sNN0029 in Patients With ALS

Amyotrophic Lateral Sclerosis

Belgium, Netherlands
Newron Pharmaceuticals SPA

Completed

Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa (SETTLE)

Idiopathic Parkinson's Disease

Korea, Republic of, Israel, Thailand, New Zealand, Spain, Canada, United States, Switzerland, Netherlands, Taiwan, United Kingdom, Belgium, Estonia, Germany, Hungary, India, Australia, Austria, France, Malaysia, Slovakia
Newron Pharmaceuticals SPA

Completed

A Study to Assess the Effect of Safinamide on Levodopa Pharmacokinetics

Idiopathic Parkinson's Disease

Italy
Newron Pharmaceuticals SPA

Completed

18-month Study of Long-term Efficacy & Safety of Safinamide as add-on Therapy in Patients With Mid-late Stage PD

Parkinson's Disease
Newron Pharmaceuticals SPA

Completed

Efficacy and Safety of Safinamide (50 and 100mg/Day) Versus Placebo, in Patients With Mid-late Stage Parkinson's Disease

Parkinson's Disease
Newron Pharmaceuticals SPA

Completed

Safinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist

Idiopathic Parkinson's Disease
Newron Pharmaceuticals SPA

Terminated

Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms (STARS)

Rett Syndrome

United States, India, United Kingdom, Australia, Italy
Newron Pharmaceuticals SPA

Terminated

Open-Label Trial to Determine the Long-Term Safety of Safinamide in Parkinson's Disease Patients

Parkinson's Disease

Romania
Newron Pharmaceuticals SPA

Terminated

A Study to Evaluate Safinamide's Effect on Dopamine and Serotonin's Availability by Using Brain Imaging

Parkinson Disease

United States
Newron Pharmaceuticals SPA

Completed

A Study to Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia

Chronic Schizophrenia

United States, India
Newron Sweden AB

Terminated

A Safety Study of sNN0029 Administration Via Intracerebroventricular Route to Patients With ALS

Amyotrophic Lateral Sclerosis

Belgium, Netherlands
Newron Pharmaceuticals SPA

Completed

MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist (MOTION)

Idiopathic Parkinson's Disease

United States, Spain, Brazil, Peru, Colombia, Germany, Argentina, India, Croatia, Czech Republic, Italy, South Africa, Finland, Portugal, Canada, Slovakia, Bulgaria, Chile, Mexico, Poland
Newron Pharmaceuticals SPA

Completed

Safinamide in Levodopa Induced Dyskinesia in Parkinson's Disease Subjects (Safinamide-LID)

Parkinson's Disease

Austria, Canada, France, Germany, South Africa
Newron Pharmaceuticals SPA

Terminated

MOTION, Safinamide in Early Idiopathic Parkinson's Disease (IPD), as add-on to Dopamine Agonist (Extension of Trial 27918) (MOTION)

Idiopathic Parkinson's Disease

Switzerland
Newron Pharmaceuticals SPA

Completed

Safinamide Renal Impairment Trial

Renal Impairment

Germany
Newron Pharmaceuticals SPA

Completed

A Study to Assess the Effect of Hepatic Impairment on Safinamide Pharmacokinetics

Hepatic Impairment

Germany
Newron Pharmaceuticals SPA

Completed

Phase II Dose Titration Study in Patients With Neuropathic Pain

Neuropathic Pain

United Kingdom, Czech Republic, Poland, Italy, India, Austria
yasmeen magdi sholkamy

Unknown

Prevalence of Chronic Oral Graft Versus Host Disease Risk Factors in Pediatric Patients

Oral Disease | Pediatric Disorder | Stem Cell Transplant Complications | Graft-versus-host-disease
Faculty Sao Leopoldo Mandic Campinas

Unknown

Relationship Between Oral Hygiene in Newborns and Candida Spp.

Candidiasis, Oral

Brazil
Faculty Sao Leopoldo Mandic Campinas

Unknown

Endodontic Treatment Using CTZ Paste in Primary Teeth (SLM2204)

Pulpectomy Agents

Brazil
Faculty Sao Leopoldo Mandic Campinas

Completed

Effectiveness of Atraumatic Restorative Treatment Using Glass Ionomer Cement of Different Costs (SLM1797)

Dental Caries

Brazil
Faculty Sao Leopoldo Mandic Campinas

Completed

Alignment Efficiency of Two Thermal Activated Orthodontic Archwire Sequences

Crowding
Cairo University
Magdi Yacoub Heart Foundation

Recruiting

Impact of Education Level on Clinical Outcomes in Self-INR Managed Patients

Atrial Fibrillation and Flutter | Mechanical Mitral Valve Prosthesis

Egypt
Gulam Manji
Daiichi Sankyo

Active, not recruiting

PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors (PLX3397)

Sarcoma | Malignant Peripheral Nerve Sheath Tumors

United States
Sohag University
Magdi Yacoub Heart Foundation

Active, not recruiting

The Role of Multislice Computed Tomography in Congenital Heart Diseases in Paediatric Age Group.

Congenital Heart Diseases

Egypt
Erin Newton
Indiana University; NOW Foods

Withdrawn

Trial of Oral Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias

Arthralgia | Breast Neoplasm Female

United States
Massachusetts General Hospital
Newton-Wellesley Hospital

Completed

Pilot RCT Comparing Effectiveness of Two Decision Aids for Hip and Knee Osteoarthritis

Knee Osteoarthritis | Hip Osteoarthritis

United States
Franklin Pierce University
Newton-Wellesley Hospital

Completed

Patients With Neck Pain Likely to Benefit From Thoracic Spine Thrust Mobilization

Neck Pain

United States

Clinical Trials Sponsored by Mandi Newton

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations